26 Jun 2025 11:29 CEST

Issuer

Oncoinvent ASA

Bergen, 26 June 2025: BerGenBio ASA held its annual general meeting today
digitally through Lumi AGM. All resolutions were made in accordance with the
proposals from the board of directors and the nomination committee, including,
but not limited to, approval of the 2024 annual accounts, election of a member
to and the remuneration the board of directors and nomination committee.

The minutes from the annual general meeting are attached hereto and will also be
made available on the company's website www.bergenbio.no.

For further information, please contact:

Olav Hellebø, CEO, BerGenBio ASA, ir@bergenbio.com

Rune Skeie, CFO, BerGenBio ASA, rune.skeie@bergenbio.com

This information is subject to the disclosure requirements pursuant to Section 5
-12 of the Norwegian Securities Trading Act.


650106_BerGenBio_ASA_AGM_minutes_26_June_2025.pdf

Source

BerGenBio ASA

Provider

Oslo Børs Newspoint

Company Name

BERGENBIO

ISIN

NO0013251173

Symbol

BGBIO

Market

Euronext Oslo Børs